Is VERU up or down today?
VERU is down 1.20% today, last at 2.47. This stock moved -1.20% versus the prior close.
VERU · VERU
VERU (VERU) is trading at 2.47, down 1.20% on the session. VERU sits at the 8% mark of its 52-week range, carries a 14-day RSI of 43, and trades below its 50-day average. Over the past month it is down 11.47%.
Leading the coverage: “Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference” (Yahoo, 9d ago). VERU is -7.81% since story.
VERU trades on a trailing P/E of 15.6 and is running 10.78% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
VERU is down 1.20% today, last at 2.47. This stock moved -1.20% versus the prior close.
Leading the coverage: “Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference” (Yahoo, 9d ago). VERU is -7.81% since story. Dominant story: Veru at 12th Annual Cantor Fitzgerald Global Healthcare Conference: muscle focus - Investing.com Canada (1 source, neutral) RSI is 43 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Veru at 12th Annual Cantor Fitzgerald Global Healthcare Conference: muscle focus - Investing.com Canada
Veru refocuses sabizabulin on post-daraxonrasib oncology - TipRanks
Veru Inc. Announces Sabizabulin Overcomes Daraxonrasib Resistance in Preclinical Pancreatic Cancer Studies and Advances Phase 2b Development Plan - Quiver Quantitative
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference